For identifying CML-related laboratory features at low cancer load, the most sensitive test is polymerase chain reaction (PCR) detecting BCR::ABL1, followed by cytogenetic test detecting Ph, and then, full blood count (FBC) primarily identifying leucocytosis. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.